% 1,169,345 19% 1,169,694 16% 1,169,694 18% Warrants 11,726 0% 14,511 0% 25,057 0% 29,627 0% Other components of equity 24,844 0% (4,250) 0% (4,232) 0% (4) 0% Retained earnings (Deficit) - 0% - 0% - 0% - 0
495 million and THB 155 million for the 3rd quarter of 2017 and 2016, respectively. To this extent, the Company would like to provide the following explanations. Revenue from sales and cost of goods
Ended March 31, 2017 (Unit: THB million) Particulars March 31, 2017 December 31, 2016 December 31, 2015 December 31, 2014 Revenue from sales1 2,772.86 10,014.15 10,566.11 9,427.85 Total revenue 4,197.62
per share. These private placements of newly issued shares would be significant transactions as they would affect the earnings ratio or the voting rights of shareholders (EPS/Control Dilution) at a
clarifies the changes in the performance over 20% as follows: FINANCIAL PERFORMANCE Consolidated Financial Statements Q2 2016 Q2 2017 Increase/(Decrease) THB mm THB mm THB mm % Total Revenue/1 1,492.8 2,714.4
Microsoft Word - Draft MD&A_E Q3_2561_9.11.18 Management Discussion and Analysis: MD&A 1. Company Situation The company’s revenue for Q3/2018 has greatly increased compared to the revenue for Q3/2017
ขายหลักทรัพย III. KEY INFORMATION A. Selected Financial Data ขอมูลท่ีสําคัญทางการเงิน B. Capitalization and Indebtedness โครงสรางเงินทุนและและภาระผูกพัน C. Reasons for the Offer and Use of Proceeds
Comprehensive Income Revenue from Hospital Operations The Company and its subsidiary generated the total revenues from hospital operations for the 2nd quarter of the year 2016 and 2017 in amounts of Baht 280.3
compensation remuneration type, and accrued expense of the latest year’s compensation; (2) To clearly disclose the use of proceeds in each determined topic and approximately specify the amount and period of
executives’ compensation policy, method of determining the compensation packages, and structures of each compensation type;- To improve disclosure of the use of proceeds in filing documents to be more